Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re 148 reexam Claim #4

The '148 Markman was very favorable to the patent claims, including your theory. If you go to the USPTO Image File Wrapper on the '336 and read the full response by TPL/Moore I belive that you will find much more than just a rebuttal to the INMOS material claimed as prior art.

 

 

Be well

Share
New Message
Please login to post a reply